Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

I. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10


Michel, Maurice; Armandi, Angelo; Gieswinkel, Alexander et al.

Risk of all-cause mortality and adverse outcomes from steatotic liver disease and its subgroups in the general population

JOURNAL OF HEPATOLOGY. Bd. 80. 2024 S. S461-S462


Michel, Maurice; Armandi, Angelo; Gieswinkel, Alexander et al.

RISK OF ALL-CAUSE MORTALITY AND ADVERSE OUTCOMES FROM STEATOTIC LIVER DISEASE AND ITS SUBGROUPS IN THE GENERAL POPULATION

HEPATOLOGY. Bd. 80. 2024 S. S799-S800


Bitzer, Michael; Gross, Sabrina; Albert, Joerg et al.

S3 guideline "Diagnostics and therapy of hepatocellular carcinoma" - long version 4.0

ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 62. H. 01. 2024 S. e67-e161


Gross, Sabrina; Bitzer, Michael; Albert, Joerg et al.

S3 guideline "Diagnostics and therapy of hepatocellular carcinoma" - short version

ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 62. H. 01. 2024 S. 73-109


Gross, Sabrina; Bitzer, Michael; Albert, Joerg et al.

S3 guideline "Diagnostics and treatment of biliary carcinomas" - long version 4.0

ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 62. H. 02. 2024 S. e213-e282


Bitzer, Michael; Gross, Sabrina; Albert, Joerg et al.

S3 guideline "Diagnostics and treatment of biliary carcinomas" - short version

ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 62. H. 02. 2024 S. 231-260




Armandi, Angelo; Bespaljko, Helena; Mang, Alexander et al.

Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept study

ALIMENTARY PHARMACOLOGY & THERAPEUTICS. Bd. 59. H. 10. 2024 S. 1212-1222